The landscape of global healthcare is undergoing a seismic shift as Sheba Medical Center, Israel’s largest and most prominent healthcare…
Read More
Aptar Pharma and Macquarie University Partner in Three-Year Initiative to Advance Pulmonary Delivery of Biologic Medicines
Drug delivery specialist Aptar Pharma has announced a strategic three-year research collaboration with Macquarie University in Australia, aimed at optimizing…
Read More
Amsbio and Atelerix Partner to Introduce Room-Temperature Cell Storage and Transportation Technology
Oxford-based life sciences provider Amsbio has entered into a strategic commercial partnership with Newcastle-headquartered biotechnology innovator Atelerix to distribute a…
Read More
Eli Lilly and Partner QurCan Therapeutics Form Strategic Alliance to Advance Next-Generation Genetic Medicines for Nervous System Disorders
The landscape of genetic medicine took a significant stride forward as pharmaceutical giant Eli Lilly and Company joined forces with…
Read More
Cellares and GenomeFrontier Therapeutics Partner to Automate Virus-Free CAR-T Cell Therapy Manufacturing on the Cell Shuttle Platform
The global cell therapy landscape is undergoing a profound structural shift as biotechnology innovators increasingly look toward end-to-end automation to…
Read More
Gilead Sciences and PAHO Partner to Expand Twice-Yearly Lenacapavir PrEP Access Across Latin America and the Caribbean
The landscape of global human immunodeficiency virus (HIV) prevention is undergoing a critical transformation following a landmark agreement between biopharmaceutical…
Read More
How Sheba Medical Center became OpenAI’s first international hospital partner
The landscape of global healthcare is undergoing a radical transformation as Sheba Medical Center, Israel’s largest hospital, officially becomes the…
Read More
Cellares and Papillon Therapeutics Partner to Automate Manufacturing of Investigational Therapy for Friedreich’s Ataxia
In a significant development for the rare disease community, Cellares and Papillon Therapeutics have announced a strategic collaboration aimed at…
Read More
Eli Lilly and Profluent Partner to Harness AI for Advanced Recombinase-Based Gene Editing
Eli Lilly and Company, a global leader in pharmaceutical innovation, has announced a significant strategic alliance with Profluent, an artificial…
Read MoreYOU MAY HAVE MISSED
